Tens of thousands of cases of eye drops have been recalled by BRS Analytical Services. The recall was initiated on April 23.

The FDA recalled eye drops, which were intended to soothe dry, itchy eyes, because of a “lack of assurance of sterility.” ...

A nationwide recall has been issued for a number of eye care products in the U.S. as officials urged people to stop using them "immediately." ...

Nearly 76,000 cases of eye drops have been recalled nationwide by BRS Analytical Services, a pharmaceutical consulting firm, according to an FDA enforcement report. The urgent recall follows an ...

More than 1.8 million eye drop bottles distributed nationwide are being recalled because the products may not be ...

The week of May 12 saw four major recalls over a range of issues, including undeclared allergens and Listeria concerns. Check ...

BRS Analytical Services, LLC, a pharmaceutical testing laboratory, had issued a nationwide recall on April 23 to over-the-counter ophthalmic products.

The issue was discovered during an audit by the FDA and impacts certain eyedrops sold between May 2023 and April 2025.

The products in question were shipped out up until recently. The distributor recommends that further use of the products ...

Nationwide recall affects five types of dry eye treatments due to manufacturing violations and sterility concerns.